Global Biologic Drugs Market Professional Survey Report 2017

Published Date : 2017-10-05

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 104

This report studies Biologic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others

By Application, the market can be split into
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Biologic Drugs Market Professional Survey Report 2017
1 Industry Overview of Biologic Drugs
1.1 Definition and Specifications of Biologic Drugs
1.1.1 Definition of Biologic Drugs
1.1.2 Specifications of Biologic Drugs
1.2 Classification of Biologic Drugs
1.2.1 Humira
1.2.2 Remicade
1.2.3 Rituxan
1.2.4 Enbrel
1.2.5 Lantus
1.2.6 Avastin
1.2.7 Herceptin
1.2.8 Others
1.3 Applications of Biologic Drugs
1.3.1 Diabetes
1.3.2 Inflammation
1.3.3 Auto-Immune Diseases
1.3.4 Blood Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Biologic Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biologic Drugs
2.3 Manufacturing Process Analysis of Biologic Drugs
2.4 Industry Chain Structure of Biologic Drugs

3 Technical Data and Manufacturing Plants Analysis of Biologic Drugs
3.1 Capacity and Commercial Production Date of Global Biologic Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Biologic Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Biologic Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Biologic Drugs Major Manufacturers in 2016

4 Global Biologic Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Biologic Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Biologic Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Biologic Drugs Sales and Growth Rate Analysis
4.3.2 2016 Biologic Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Biologic Drugs Sales Price
4.4.2 2016 Biologic Drugs Sales Price Analysis (Company Segment)

5 Biologic Drugs Regional Market Analysis
5.1 North America Biologic Drugs Market Analysis
5.1.1 North America Biologic Drugs Market Overview
5.1.2 North America 2012-2017E Biologic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Biologic Drugs Sales Price Analysis
5.1.4 North America 2016 Biologic Drugs Market Share Analysis
5.2 China Biologic Drugs Market Analysis
5.2.1 China Biologic Drugs Market Overview
5.2.2 China 2012-2017E Biologic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Biologic Drugs Sales Price Analysis
5.2.4 China 2016 Biologic Drugs Market Share Analysis
5.3 Europe Biologic Drugs Market Analysis
5.3.1 Europe Biologic Drugs Market Overview
5.3.2 Europe 2012-2017E Biologic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Biologic Drugs Sales Price Analysis
5.3.4 Europe 2016 Biologic Drugs Market Share Analysis
5.4 Southeast Asia Biologic Drugs Market Analysis
5.4.1 Southeast Asia Biologic Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Biologic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Biologic Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Biologic Drugs Market Share Analysis
5.5 Japan Biologic Drugs Market Analysis
5.5.1 Japan Biologic Drugs Market Overview
5.5.2 Japan 2012-2017E Biologic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Biologic Drugs Sales Price Analysis
5.5.4 Japan 2016 Biologic Drugs Market Share Analysis
5.6 India Biologic Drugs Market Analysis
5.6.1 India Biologic Drugs Market Overview
5.6.2 India 2012-2017E Biologic Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Biologic Drugs Sales Price Analysis
5.6.4 India 2016 Biologic Drugs Market Share Analysis

6 Global 2012-2017E Biologic Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Biologic Drugs Sales by Type
6.2 Different Types of Biologic Drugs Product Interview Price Analysis
6.3 Different Types of Biologic Drugs Product Driving Factors Analysis
6.3.1 Humira of Biologic Drugs Growth Driving Factor Analysis
6.3.2 Remicade of Biologic Drugs Growth Driving Factor Analysis
6.3.3 Rituxan of Biologic Drugs Growth Driving Factor Analysis
6.3.4 Enbrel of Biologic Drugs Growth Driving Factor Analysis
6.3.5 Lantus of Biologic Drugs Growth Driving Factor Analysis
6.3.6 Avastin of Biologic Drugs Growth Driving Factor Analysis
6.3.7 Herceptin of Biologic Drugs Growth Driving Factor Analysis
6.3.8 Others of Biologic Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Biologic Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Biologic Drugs Consumption by Application
7.2 Different Application of Biologic Drugs Product Interview Price Analysis
7.3 Different Application of Biologic Drugs Product Driving Factors Analysis
7.3.1 Diabetes of Biologic Drugs Growth Driving Factor Analysis
7.3.2 Inflammation of Biologic Drugs Growth Driving Factor Analysis
7.3.3 Auto-Immune Diseases of Biologic Drugs Growth Driving Factor Analysis
7.3.4 Blood Diseases of Biologic Drugs Growth Driving Factor Analysis
7.3.5 Cardiovascular Diseases of Biologic Drugs Growth Driving Factor Analysis
7.3.6 Others of Biologic Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Biologic Drugs
8.1 Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Roche 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Roche 2016 Biologic Drugs Business Region Distribution Analysis
8.2 Abbott Laboratories
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Abbott Laboratories 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Abbott Laboratories 2016 Biologic Drugs Business Region Distribution Analysis
8.3 Johnson & Johnson
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Johnson & Johnson 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Johnson & Johnson 2016 Biologic Drugs Business Region Distribution Analysis
8.4 Merck & Co.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Merck & Co. 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Merck & Co. 2016 Biologic Drugs Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Pfizer 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2016 Biologic Drugs Business Region Distribution Analysis
8.6 Amgen
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Amgen 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Amgen 2016 Biologic Drugs Business Region Distribution Analysis
8.7 Sanofi
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Sanofi 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sanofi 2016 Biologic Drugs Business Region Distribution Analysis
8.8 Novartis
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Novartis 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Novartis 2016 Biologic Drugs Business Region Distribution Analysis
8.9 Eli Lilly
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Eli Lilly 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Eli Lilly 2016 Biologic Drugs Business Region Distribution Analysis
8.10 Amgen
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Amgen 2016 Biologic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Amgen 2016 Biologic Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Biologic Drugs Market
9.1 Global Biologic Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Biologic Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Biologic Drugs Sales Price Forecast
9.2 Biologic Drugs Regional Market Trend
9.2.1 North America 2017-2022 Biologic Drugs Consumption Forecast
9.2.2 China 2017-2022 Biologic Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Biologic Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Biologic Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Biologic Drugs Consumption Forecast
9.2.6 India 2017-2022 Biologic Drugs Consumption Forecast
9.3 Biologic Drugs Market Trend (Product Type)
9.4 Biologic Drugs Market Trend (Application)

10 Biologic Drugs Marketing Type Analysis
10.1 Biologic Drugs Regional Marketing Type Analysis
10.2 Biologic Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biologic Drugs by Region
10.4 Biologic Drugs Supply Chain Analysis

11 Consumers Analysis of Biologic Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 Conclusion of the Global Biologic Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source



List of Tables and Figures
Figure Picture of Biologic Drugs
Table Product Specifications of Biologic Drugs
Table Classification of Biologic Drugs
Figure Global Production Market Share of Biologic Drugs by Type in 2016
Figure Humira Picture
Table Major Manufacturers of Humira
Figure Remicade Picture
Table Major Manufacturers of Remicade
Figure Rituxan Picture
Table Major Manufacturers of Rituxan
Figure Enbrel Picture
Table Major Manufacturers of Enbrel
Figure Lantus Picture
Table Major Manufacturers of Lantus
Figure Avastin Picture
Table Major Manufacturers of Avastin
Figure Herceptin Picture
Table Major Manufacturers of Herceptin
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Biologic Drugs
Figure Global Consumption Volume Market Share of Biologic Drugs by Application in 2016
Figure Diabetes Examples
Table Major Consumers in Diabetes
Figure Inflammation Examples
Table Major Consumers in Inflammation
Figure Auto-Immune Diseases Examples
Table Major Consumers in Auto-Immune Diseases
Figure Blood Diseases Examples
Table Major Consumers in Blood Diseases
Figure Cardiovascular Diseases Examples
Table Major Consumers in Cardiovascular Diseases
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Biologic Drugs by Regions
Figure North America Biologic Drugs Market Size (Million USD) (2012-2022)
Figure China Biologic Drugs Market Size (Million USD) (2012-2022)
Figure Europe Biologic Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Biologic Drugs Market Size (Million USD) (2012-2022)
Figure Japan Biologic Drugs Market Size (Million USD) (2012-2022)
Figure India Biologic Drugs Market Size (Million USD) (2012-2022)
Table Biologic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biologic Drugs in 2016
Figure Manufacturing Process Analysis of Biologic Drugs
Figure Industry Chain Structure of Biologic Drugs
Table Capacity and Commercial Production Date of Global Biologic Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Biologic Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Biologic Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Biologic Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Biologic Drugs 2012-2017
Figure Global 2012-2017E Biologic Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Biologic Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Biologic Drugs Capacity and Growth Rate
Table 2016 Global Biologic Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Biologic Drugs Sales (K Units) and Growth Rate
Table 2016 Global Biologic Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Biologic Drugs Sales Price (USD/Unit)
Table 2016 Global Biologic Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Biologic Drugs 2012-2017E
Figure North America 2012-2017E Biologic Drugs Sales Price (USD/Unit)
Figure North America 2016 Biologic Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Biologic Drugs 2012-2017E
Figure China 2012-2017E Biologic Drugs Sales Price (USD/Unit)
Figure China 2016 Biologic Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Biologic Drugs 2012-2017E
Figure Europe 2012-2017E Biologic Drugs Sales Price (USD/Unit)
Figure Europe 2016 Biologic Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Biologic Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Biologic Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Biologic Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Biologic Drugs 2012-2017E
Figure Japan 2012-2017E Biologic Drugs Sales Price (USD/Unit)
Figure Japan 2016 Biologic Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Biologic Drugs 2012-2017E
Figure India 2012-2017E Biologic Drugs Sales Price (USD/Unit)
Figure India 2016 Biologic Drugs Sales Market Share
Table Global 2012-2017E Biologic Drugs Sales (K Units) by Type
Table Different Types Biologic Drugs Product Interview Price
Table Global 2012-2017E Biologic Drugs Sales (K Units) by Application
Table Different Application Biologic Drugs Product Interview Price
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Biologic Drugs Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Laboratories Biologic Drugs Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2015 Johnson & Johnson Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Biologic Drugs Business Region Distribution
Table Merck & Co. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co. Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck & Co. Biologic Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Biologic Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Biologic Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Biologic Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Biologic Drugs Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly Biologic Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Biologic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Biologic Drugs Business Region Distribution
Figure Global 2017-2022 Biologic Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Biologic Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Biologic Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Biologic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Biologic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Biologic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Biologic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Biologic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Biologic Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Biologic Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Biologic Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Biologic Drugs by Region

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com